NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
(855) 940-4867
Schema Widget
1450 Frazee Road
Suite 210
San Diego, CA 92108
Holiday weekend, and extended hours by appointment
Welcome to Greenbrook TMS in Mission Valley
855-940-4867
Greenbrook TMS is Mission Valley's most trusted provider of Transcranial Magnetic Stimulation (TMS) therapy and Spravato® nasal esketamine spray for the treatment of depression. TMS is an FDA-cleared, non-drug, non-invasive therapy for the treatment of Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD). Spravato® is an FDA-approved nasal esketamine spray, a more specific form of ketamine designed to treat depression.
Most major insurance companies cover our treatments. Schedule a no-cost consultation today with a member of our Mission Valley Care Team to determine if they are right for you.
Directions: There is parking all around the building. When entering, take the elevator to the second floor. Go right and Greenbrook TMS is at the end of the hall on the left hand side in Suite 210.
Depression treatment in Mission Valley
With a population of 23,000, Mission Valley has much to offer and appreciate. But life can be hard to enjoy when you're dealing with depression.
If you're still depressed after trying antidepressants and talk therapy, TMS therapy and nasal esketamine are offered right here in Mission Valley and are covered by most insurance. Schedule a no-cost consultation today, and we'll help you find a depression treatment that's right for you. Our friendly Greenbrook Mission Valley Care Team will be with you through every step of the process, from insurance to scheduling. We're here to answer any questions you have.
To get started, schedule your no-cost consultation. You'll meet with your Consultant Coordinator during your consultation to review your history and explain the treatment process. Next, you'll meet with a Greenbrook provider for an evaluation, which includes questions about your history and symptoms. If the Greenbrook provider has determined that you're a candidate for Spravato® or TMS therapy and you're ready to move forward, they will create your individualized treatment plan. Then, you're ready to start treatment at Greenbrook Mission Valley!
More about TMS therapy
What is TMS therapy?
TMS is an FDA-cleared, non-drug, non-invasive therapy for the treatment of Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD). Using the same magnetic technology found in MRI machines, TMS therapy stimulates the areas of the brain responsible for mood. TMS provides depression symptom relief for about 83% of people who try it after antidepressants have proven ineffective.
How long is TMS therapy treatment?
TMS therapy lasts six to nine weeks, with treatment in the first phase being five days a week, then tapering off to only a couple of days per week. Each TMS session takes 18-45 minutes while you remain seated in a comfortable chair at our private center. Treatment schedules and duration vary from patient to patient, and your Greenbrook provider will explain your recommended treatment plan during your evaluation.
Is there downtime after TMS?
No, you can leave immediately following a TMS session and resume your normal daily activities with zero downtime. Most patients report either no side effects at all, or some minor discomfort (such as a mild headache) after the first few TMS sessions.
More about Spravato® nasal esketamine treatment
What is Spravato®?
Spravato® is an FDA-approved nasal esketamine spray, a more specific form of ketamine designed to treat depression. Many major insurance companies cover this treatment.
What should I expect during a nasal esketamine treatment session?
Each session occurs at our private, spa-like Greenbrook Mission Valley center. Once you arrive, you'll sit in a comfortable chair and self-administer the nasal spray under the supervision of our Care Team. You can expect to feel side effects such as mild sedation or disassociation during treatment. You will need to stay in our center for no less than two hours during treatment to be monitored by a healthcare professional who will be available to assist you. Ensure you have someone to help you get home, as you cannot operate a motor vehicle or other heavy machinery for the rest of the day.
How long is Spravato® treatment?
A typical round of Spravato® esketamine nasal spray treatment is broken up into three phases:
Phase 1: 2 treatments a week for four weeks
Phase 2: 1 treatment a week for four weeks
Phase 3: 1 treatment every 1-2 weeks for maintenance
At most Greenbrook centers, we try to book your Spravato® treatments to accommodate your schedule, whether morning or afternoon appointments work best for you.
<p class="rteBlock">California</p>
<p class="rteBlock">Mission Valley</p>
Please provide the requested information below and Greenbrook TMS will contact you shortly. All information will be kept strictly Confidential. We do not sell or share your information.
** If you are a Referring Physician interested in contacting Greenbrook TMS about a current patient, please use this form.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.